Medical News & Perspectives  Quick Uptakes February 14, 2024 When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike Rita Rubin JAMA. Published online February 14, 2024. doi:10.1001/jama.2024.1014 For people who are immunocompromised, the COVID-19 pandemic is not over. In general, their immune system’s response to COVID-19 vaccines and to SARS-CoV-2 infection is blunted compared with individuals who...

Original Investigation  January 30, 2024 Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial Tarah T. Colaizy, Brenda B. Poindexter, Scott A. McDonald, et al JAMA. 2024;331(7):582-591. doi:10.1001/jama.2023.27693 Key Points Question  Among extremely preterm infants fed minimal maternal milk, does feeding of donor human milk compared with preterm formula du...

Original Investigation  Pediatrics February 14, 2024 Hospital-Level NICU Capacity, Utilization, and 30-Day Outcomes in Texas David C. Goodman, Patrick Stuchlik, Cecilia Ganduglia-Cazaban, et al JAMA Netw Open. 2024;7(2):e2355982. doi:10.1001/jamanetworkopen.2023.55982 Key Points Question  Is hospital-level neonatal intensive care unit (NICU) bed supply associated with higher risk-adjusted newborn utilization and better outcome...

VENT-AVOID Trial: ECCO2R to Avoid IMV During Exacerbation of COPD In patients experiencing exacerbation of chronic obstructive pulmonary disease (ECOPD), invasive mechanical ventilation (IMV) is linked with increased morbidity and mortality. Extracorporeal CO2removal (ECCO2R) has been used to prevent intubation in those at risk of NIV failure and to aid early extubation from IMV. However, current evidence supporting the efficacy of ECCO2R devices in reducing or avo...

Original Investigation  Medical Education February 14, 2024 Effectiveness of Virtual Reality Training in Teaching Personal Protective Equipment Skills: A Randomized Clinical Trial Keisuke Tsukada, Youichi Yasui, Satoshi Miyata, et al JAMA Netw Open. 2024;7(2):e2355358. doi:10.1001/jamanetworkopen.2023.55358 Key Points Question  Is virtual reality (VR) training effective in teaching donning and doffing of personal protective eq...

Original Investigation  February 20, 2024 Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction Nick Graetz, Peter Hepburn, Carl Gershenson, et al JAMA. 2024;331(7):592-600. doi:10.1001/jama.2023.27005 Key Points Question  What were the patterns of excess mortality associated with the COVID-19 pandemic among renters who received eviction filings? Findings  In this retro...

Original Investigation  February 14, 2024 Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial Tara M. Mackay, Anouk E. J. Latenstein, Simone Augustinus, et al JAMA Surg. Published online February 14, 2024. doi:10.1001/jamasurg.2023.7872 Key Points Question  Can enhanced nationwide implementation of guideline-based best practice...

Exploring Post-ICU Impairment With the increasing survival rates in the ICU, there is more focus on improving the quality of survival. Post-intensive care syndrome (PICS), characterised by cognitive, psychological, and physical impairments affecting up to 80% of ICU survivors, remains a significant challenge despite extensive research. Identifying the risk factors and understanding how they affect recovery is crucial for developing effective prevention and treatmen...

Research Letter  February 15, 2024 Prevalence of Immunosuppression Among US Adults Melissa L. Martinson, Jessica Lapham JAMA. Published online February 15, 2024. doi:10.1001/jama.2023.28019 The prevalence of immunosuppression from health conditions and medication use among US adults is often reported to be about 3%, which is based on an estimate of 2.7% from nationally representative data1 from 2013 and an estimate of 2.8% for the preval...

COMMENT|ONLINE FIRST Improved precision in defining the need for thromboprophylaxis during lower limb immobilisation Beverley J Hunt, Xavier L Griffin Lancet Published: February 15, 2024 DOI:https://doi.org/10.1016/S0140-6736(23)02613-2 Hospital-associated venous thromboembolism is defined as venous thromboembolism occurring during hospital admission and up to 90 days after discharge. It is the major cause of venous thromboembolism, accounting for over 50% ...